MSTN and diabetes mellitus: By using this assay, it was suggested for example, that serum myostatin levels are increased or decreased in patients with chronic heart failure [20-23], increased or unchanged in diabetes mellitus type 2 and perhaps reduced in adult patients with Pompe disease [32,33,38].